docetaxel and epirubicin plus endostatin

DRUG2 trials

Sponsors

Xijing Hospital

Conditions

Breast Cancer

Phase 2

Neoadjuvant Endostatin and Chemotherapy for Breast Cancer

CompletedNCT00604435

Xijing HospitalBreast Cancer

Start: 2008-02-29End: 2010-01-31Updated: 2010-01-20

Phase 3

Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer

Xijing HospitalBreast Cancer

Start: 2011-10-31End: 2015-02-28Target: 800Updated: 2011-11-24

Related Papers

Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study.

2013-05-2129 citations